When administered to juvenile rats, melanotan II elicits positive effects on the hypothalamic neurocircuitry system, as well as the homeostatic conditions of body weight, NPY expressions, and energy expenditure
These molecular changes correlated with clinical motor improvements, suggesting a potential disease-modifying effect consistent with other trials showing both motor and cognitive benefits as well as biomarker evidence of enhanced insulin and neurotrophic signaling [32, 55]
female rats experience brief estrogen peaks during proestrus rather than the sustained elevations observed across the human menstrual cycle (Staley and Scharfman 2005
underpowered, not double-blinded, not placebo-controlled and disparities in iodine intake were not considered ( Reference Wichman, Bonnema and Hegedus 88 , Reference van Zuuren, Albusta and Fedorowicz 89 , Reference Duntas and Benvenga 91 )